NYSE Issues Listing Certification for GSK plc
GSK plc
Subscribe to track GSK
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š GSK plc (NYSE: GSK) - Form CERT ā¢ Filing Date: September 22, 2026 ā¢ Type: Exchange Certification of Listing Approval ā¢ Exchange: New York Stock Exchange (NYSE) ā¢ Significance: Low (Administrative/Listing Action)
Comprehensive Analysis
Overview of Filing
On September 22, 2026, a Form CERT filing was submitted to the U.S. Securities and Exchange Commission (SEC) on behalf of GSK plc (CIK: 0001131399, SEC File No. 001-15170).
Key Filing Details
- Document Type: Form CERT (Exchange Certification)
- Description: NYSE Certification verifying approval for the listing and registration of securities under the Securities Exchange Act of 1934.
- Filer: GSK plc
- Standard Industrial Classification (SIC): Pharmaceutical Preparations (2834)
- Business Address: 79 New Oxford Street, London, WC1A 1DG
Transaction & Market Impact Assessment
- Insider Transactions: None. Form CERT filings are regulatory notifications from securities exchanges certifying listing approval, not reports of insider equity trades or changes in beneficial ownership.
- Trading Significance: Low. This filing represents a routine administrative certification issued by the New York Stock Exchange in connection with securities listing.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.